TY - JOUR
T1 - The impact of COVID-19 on thoracic surgical procedures in Japan
T2 - Analysis of data from the National Clinical Database
AU - Sato, Yukio
AU - Yamamoto, Hiroyuki
AU - Ikeda, Norihiko
AU - Konishi, Hiroshi
AU - Endo, Shunsuke
AU - Okada, Yoshinori
AU - Kondo, Haruhiko
AU - Shintani, Yasushi
AU - Toyooka, Shinichi
AU - Nakamura, Hiroshige
AU - Hoshikawa, Yasushi
AU - Chen-Yoshikawa, Toyofumi Fengshi
AU - Yoshino, Ichiro
AU - Kakizoe, Tadao
AU - Chida, Masayuki
N1 - Publisher Copyright:
© 2022 Elsevier B.V.
PY - 2022/10
Y1 - 2022/10
N2 - Objective: The COVID-19 pandemic has far-reaching collateral health impacts on the ongoing delivery of surgical care worldwide. The current study was designed to analyze the impact of the COVID-19 pandemic on the number of surgeries of general thoracic surgery in Japan. Methods: Changes in the number of surgeries for total and three representative tumors were analyzed using the National Clinical Database data with reference to the pandemic infection rate and lung cancer screening. Results: In 2020, the number of surgeries in total and for primary lung cancer and mediastinal lung tumor decreased by 4.9, 5.1, and 5.0 %, respectively. Considering the five-year trend towards a 5 % annual increase, there was a potential 10 % decrease in the number of primary lung cancer surgeries. The number of primary lung cancer surgeries bottomed in July 2020 but recovered towards the end of the year. In contrast, the number of metastatic lung tumor surgeries in 2020 increased by 3.2 %, following a similar trend observed over the previous five years. The number of lung cancer screening examinees decreased markedly with the lowest number in May. Our findings indicate that surgical triage had a limited impact on the decrease in primary lung cancer surgeries during the pandemic; rather, the decrease in lung cancer screening, which was a few months preceding, is most likely responsible. Conclusions: The decrease in primary lung cancer was mainly caused by the decrease in lung cancer screening, indicating that continuing screening is vital even during a pandemic.
AB - Objective: The COVID-19 pandemic has far-reaching collateral health impacts on the ongoing delivery of surgical care worldwide. The current study was designed to analyze the impact of the COVID-19 pandemic on the number of surgeries of general thoracic surgery in Japan. Methods: Changes in the number of surgeries for total and three representative tumors were analyzed using the National Clinical Database data with reference to the pandemic infection rate and lung cancer screening. Results: In 2020, the number of surgeries in total and for primary lung cancer and mediastinal lung tumor decreased by 4.9, 5.1, and 5.0 %, respectively. Considering the five-year trend towards a 5 % annual increase, there was a potential 10 % decrease in the number of primary lung cancer surgeries. The number of primary lung cancer surgeries bottomed in July 2020 but recovered towards the end of the year. In contrast, the number of metastatic lung tumor surgeries in 2020 increased by 3.2 %, following a similar trend observed over the previous five years. The number of lung cancer screening examinees decreased markedly with the lowest number in May. Our findings indicate that surgical triage had a limited impact on the decrease in primary lung cancer surgeries during the pandemic; rather, the decrease in lung cancer screening, which was a few months preceding, is most likely responsible. Conclusions: The decrease in primary lung cancer was mainly caused by the decrease in lung cancer screening, indicating that continuing screening is vital even during a pandemic.
UR - http://www.scopus.com/inward/record.url?scp=85137286692&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85137286692&partnerID=8YFLogxK
U2 - 10.1016/j.lungcan.2022.08.011
DO - 10.1016/j.lungcan.2022.08.011
M3 - Article
C2 - 36084376
AN - SCOPUS:85137286692
SN - 0169-5002
VL - 172
SP - 127
EP - 135
JO - Lung Cancer
JF - Lung Cancer
ER -